摩根大通：爱尔眼科_引领眼科赛道，等待需求复苏；首次覆盖评级为中性

Aier Eye - A Leading the ophthalmic track and awaiting a recovery in demand; initiate at N We initiate coverage of Aier Eye with a N rating and a Dec-25 PT of Rmb13. Aier Eye is the leader in the structurally expanding ophthalmology market underpinned by an ageing population and escalating 'quality of life' requirements. Resilient demand for cataract and eye disease therapy ensures steady industry growth, even if the lukewarm consumer economy in China is delaying discretionary ophthalmic demand. Aier's firs ...